![]() |
Formats:
|
||||||||||||||||||||||
Copyright © 2008 The Authors Journal compilation © 2008 Blackwell Publishing Ltd Characterization of CetA and CetB, a bipartite energy taxis system in Campylobacter jejuni 1Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA 2Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, MI 48109, USA *For correspondence. E-mail vdirita/at/umich.edu; Tel. (+1) 734 936 3084; Fax (+1) 734 936 3235. Accepted June 2, 2008. Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. This article has been cited by other articles in PMC.Abstract The energy taxis receptor Aer, in Escherichia coli, senses changes in the redox state of the electron transport system via an flavin adenine dinucleotide cofactor bound to a PAS domain. The PAS domain (a sensory domain named after three proteins Per, ARNT and Sim, where it was first identified) is thought to interact directly with the Aer HAMP domain to transmit this signal to the highly conserved domain (HCD) found in chemotaxis receptors. An apparent energy taxis system in Campylobacter jejuni is composed of two proteins, CetA and CetB, that have the domains of Aer divided between them. CetB has a PAS domain, while CetA has a predicted transmembrane region, HAMP domain and the HCD. In this study, we examined the expression of cetA and cetB and the biochemical properties of the proteins they encode. cetA and cetB are co-transcribed independently of the flagellar regulon. CetA has two transmembrane helices in a helical hairpin while CetB is a peripheral membrane protein tightly associated with the membrane. CetB levels are CetA dependent. Additionally, we demonstrated that both CetA and CetB participate in complexes, including a likely CetB dimer and a complex that may include both CetA and CetB. This study provides a foundation for further characterization of signal transduction mechanisms within CetA/CetB. Introduction Motile bacteria alter the direction in which they swim based on changes in the local environment. These changes can be sensed directly in classical chemotaxis, where changes in the local concentration of a stimulus (i.e. an amino acid or sugar) are sensed in a metabolism-independent fashion, often by transmembrane methyl-accepting chemotaxis proteins (MCPs). Changes in the local environment can also be sensed indirectly by monitoring energy-generating processes within the cell. In this behaviour, termed energy taxis, receptors sense changes in the redox state of components of the electron transport system (ETS) or in the closely coupled proton motive force (Taylor and Zhulin, 1998). Energy taxis behaviours include some forms of aerotaxis, phototaxis, taxis to electron acceptors and even chemotaxis in those cases where the bacteria sense chemicals based on changes in energy generation resulting from their metabolism (Taylor and Zhulin, 1998; Taylor et al., 1999; Alexandre et al., 2004). Energy taxis receptors and their signal transduction mechanisms have been well-characterized in Escherichia coli. E. coli contains two energy taxis receptors: Tsr, a classic serine-responsive MCP that also senses changes in the proton motive force, and Aer, which senses changes in the redox state of element(s) of the ETS (Rebbapragada et al., 1997). Aer has been suggested to sense these changes via the redox state of an flavin adenine dinucleotide cofactor bound to the N-terminal PAS domain (a sensory domain named after three proteins Per, ARNT and Sim, where it was first identified) (Taylor, 2007). This signal is thought to be transmitted to the HAMP domain of Aer (named for its presence in histidine kinases, adenylyl cyclases, MCPs and phosphatases) (Aravind and Ponting, 1999) by a direct PAS–HAMP interaction (Taylor, 2007). Finally, the HAMP domain relays the signal to the highly conserved domain (HCD) (named for its prevalence in MCPs) (Taylor, 2007). Aer also possesses two transmembrane domains with a small intervening periplasmic loop, but there is, as yet, no evidence for the involvement of this region in signal transduction (Amin et al., 2006). This differs from classical MCPs which are thought to transmit signals sensed by a periplasmic domain to the HAMP and HCD domains by a shift in their transmembrane helices (Chervitz and Falke, 1996; Moukhametzianov et al., 2006). Flagellar motility plays a vital role in the pathogenicity of Campylobacter jejuni, one of the most common causes of gastroenteritis in the United States, as well as in its colonization of livestock reservoirs, most commonly poultry (Guerry, 2007; Young et al., 2007). A transposon screen of mutants with defects in motility identified insertions in cetA and cetB, adjacent genes on the C. jejuni genome that encode proteins representing a variation on the domain arrangement found in Aer (Hendrixson et al., 2001). CetB contains a predicted PAS domain and no other functional domains. CetA is predicted to contain a transmembrane region, a HAMP domain and the HCD. Mutants lacking cetA or cetB are deficient in energy taxis (Hendrixson et al., 2001). These studies led to the hypothesis that CetA and CetB interact to transduce an energy taxis signal via a similar mechanism as that proposed for the single protein Aer. Specifically, we predict that CetB interacts with the HAMP domain of CetA, as is suggested of the PAS and HAMP domains of Aer. However, significant divergence between the HAMP domains of Aer and CetA suggests that the molecular nature of these interactions likely differ (K.T. Elliott, I.B. Zhulin, J.A. Stuckey, V.J. DiRita, in revision). We have determined that CetA and CetB define a new family of HAMP/PAS containing proteins, with pairs of similar proteins identified in 22 species thus far (K.T. Elliott, I.B. Zhulin, J.A. Stuckey, V.J. DiRita, in revision). In this study, we initiated molecular and biochemical characterization of CetA and CetB, testing predictions about their transcription, topology, localization and interaction. Our studies show that cetA and cetB are co-transcribed independently of the flagellar regulon. Further, CetA and CetB are both membrane-associated: CetA by two transmembrane helices in a helical hairpin; CetB in a peripheral manner, likely via protein–protein interactions. In addition, we uncovered evidence of a likely protein–protein interaction between CetA and CetB, including low levels of CetB in the absence of CetA, and the existence of high molecular weight complexes that appear to include both proteins. Results cetA and cetB are co-transcribed independently of the flagellar regulon, and CetB levels are CetA-dependent Our hypothesis that CetA and CetB interact to transduce an energy taxis signal is based in part on the fact that they are encoded by adjacent genes on the C. jejuni chromosome. As there are 17 bp between the cetA and cetB genes, we expected that they would be co-transcribed. We tested this prediction by performing reverse transcription polymerase chain reaction (RT-PCR) using one primer within each gene (Fig. 1A
Campylobacter jejuni has only three known sigma factors identified within its genome: σ70, σ54 (encoded by rpoN) and σ28 (encoded by fliA). The latter two sigma factors are required for the flagellar transcriptional cascade in C. jejuni (Hendrixson and DiRita, 2003). Levels of CetA and CetB were unaffected in strains lacking σ54 or σ28, indicating that cetA and cetB are likely expressed in a σ70-dependent fashion (Fig. 2A
Western blots also demonstrated that CetB levels are at or below our limit of detection in the ΔcetA mutant (Fig. 2A CetA has two transmembrane domains in a helical hairpin We used the DAS (dense alignment surface) algorithm (Cserzo et al., 1997) to predict whether CetA and/or CetB possess transmembrane domains. According to this analysis, CetA has a transmembrane region of 36–38 amino acids in length from residues 6–43 or 7–42, depending on the cut-off used (Fig. 3A
The DAS analysis indicates that CetB does not have any transmembrane domains (Fig. 3B A dip in the DAS profile score is apparent at about the mid-point of the predicted transmembrane region in CetA. Closer examination of the hydrophobicity of each residue showed a strongly hydrophilic residue near the mid-point of this region (arrow, Fig. 3C To differentiate between the single transmembrane helix predicted by the DAS algorithm and our prediction that CetA has two transmembrane helices, we performed topology analysis using phoA and lacZ fusions. phoA encodes alkaline phosphatase, which is active in the periplasm and inactive in the cytoplasm. lacZ encodes β-galactosidase, an enzyme that is active in the cytoplasm and too bulky to be transported to the periplasm. Fusion of β-galactosidase to periplasmic regions of a protein leads to the embedding of the fusion in the membrane, resulting in improper folding and a loss of enzymatic activity (Froshauer et al., 1988). By comparing alkaline phosphatase and β-galactosidase activities resulting from fusions at various locations within a protein, we can develop a good prediction of the topology of that protein (Silhavy and Beckwith, 1985; Manoil and Beckwith, 1986; Manoil, 1990). We made phoA and lacZ fusions such that alkaline phosphatase or β-galactosidase would be fused C-terminally to full-length CetA or to CetA that was truncated at residue 5, 24, 50 or 140 (Fig. 4A
CetA is an integral membrane protein and CetB is a peripheral membrane protein The above phoA/lacZ fusion experiments were performed in E. coli. We sought to determine the localization of CetA and CetB in C. jejuni. To do so, we prepared and analysed subcellular fractions for localization of CetA and CetB. Wild-type C. jejuni was lysed as described in Materials and Methods. Soluble and membrane-associated proteins were then separated by ultracentrifugation. These samples were analysed for the presence of CetA and CetB by Western blot. While some CetA is detectable in the soluble fraction, the majority of both CetA and CetB are in the membrane fraction (Fig. 5
As DAS analysis indicated that CetB does not have a transmembrane region, the presence of CetB in the membrane fraction suggests that CetB is a peripheral membrane protein, associated with the membrane by protein–protein interactions or by direct interaction with the membrane. In order to determine the nature of the association of CetB with the membrane, we performed membrane extraction experiments. In these experiments, a C. jejuni strain was used that expressed a FLAG-tagged CtsP protein, which had been previously characterized by our lab as a peripheral membrane protein (R.S. Wiesner and V.J. DiRita, in preparation). The bacteria were lysed and separated into soluble and membrane fractions as described above. The membrane fraction was washed three times in 10 mM HEPES (pH 7.4) prior to treatment with urea, NaCl or buffer alone. Urea denatures proteins and disrupts protein complexes, thereby releasing peripheral membrane proteins (Gilmore and Blobel, 1985; Borel and Simon, 1996). High-salt treatment weakens ionic interactions between peripheral membrane proteins and other membrane proteins or the polar head groups of the lipid bilayer (Kretzschmar et al., 1996; Hugle et al., 2001). Integral membrane proteins should remain insoluble following treatment with urea or high salt. Peripheral membrane proteins may be soluble following urea and/or high-salt treatment depending on the nature and strength of their membrane association. After these treatments, the soluble and insoluble proteins were separated by ultracentrifugation and probed for the presence of CetA, CetB and CtsP-FLAG. CtsP was solubilized in 6 M urea (Fig. 6A
CetA and CetB associate in larger complexes In order to test further whether CetA and CetB interact with one another and/or other proteins, we performed in vivo cross-linking experiments. Cells were treated with 2.5 mM of the membrane permeable primary amine cross-linker DSP in DMSO or with DMSO alone. DSP was inactivated by addition of 50 mM Tris pH 8.0, and these samples were analysed by non-reducing SDS-PAGE and probed for CetA or CetB by Western blot. When cross-linked wild-type samples were separated on 10% SDS-PAGE and immunoblotted with anti-CetA, several species with molecular weights between approximately 115.5 and 181.8 kDa were apparent (Fig. 7A
When cross-linked wild-type samples were analysed on 12.5% SDS-PAGE, we detected two species on immunoblotting with anti-CetB (Fig. 7B The identity of each of these CetA and CetB complexes has not been definitively determined, but some inferences can be made. In particular, the largest CetA and CetB complexes are approximately the same size, consistent with a single complex containing both proteins. The molecular weight of this species is between approximately 115.5 and 181.8 kDa, which would be consistent with a complex comprised of two CetA monomers (51.0 kDa each) and two CetB monomers (19.3 kDa each). We also expect that CetA forms a homodimer, as do other MCPs, and this could be one of the CetB-independent species present in the blot shown in Fig. 7A Discussion In this study, we carried out molecular and biochemical characterization of CetA and CetB, a putative bipartite energy taxis system of C. jejuni. The data we present support a model in which we hypothesize that a membrane-associated CetB dimer serves as a signal-sensing protein and transmits that signal to the integral membrane protein CetA via a direction interaction (Fig. 8
CetA and CetB are encoded by adjacent genes 17 bp apart on the C. jejuni chromosome. Based on the small intergenic distance, as well as the fact that both are required for energy taxis (Hendrixson et al., 2001), we expected that cetA and cetB would be co-transcribed. RT-PCR analysis indicated that this is the case (Fig. 1 Topology prediction programmes indicated that CetA contains a single, fairly long transmembrane helix, and that CetB is entirely cytoplasmic (Fig. 3A and B The sequence analysis and fusion data indicate that CetA is an integral membrane protein and CetB is cytoplasmic. We further examined the subcellular location of both CetA and CetB when expressed from the chromosome of C. jejuni. These experiments demonstrated that both CetA and CetB localize to the membrane of C. jejuni (Fig. 5 Based on the fact that CetA and CetB possess all of the domains of the energy taxis receptor Aer and are required for energy taxis by C. jejuni (Hendrixson et al., 2001), we predict that CetA and CetB interact directly to transduce an energy taxis signal. We observed that CetB levels are extremely low in the absence of CetA, whether CetB is expressed from the chromosome or from a multicopy plasmid (Fig. 2 Evidence of an interaction between CetA and CetB was obtained from in vivo cross-linking experiments. In these experiments, whole cells were treated with the membrane permeable primary amine cross-linker DSP. When the cross-linked samples were probed for the presence of CetA by Western blot, a high molecular weight species was evident in the wild-type sample that was absent in the ΔcetB mutant sample (Fig. 7A The HAMP domains of CetA and Aer differ significantly (K.T. Elliott, I.B. Zhulin, J.A. Stuckey, V.J. DiRita, in revision). Based on similarity to the HAMP domain of CetA, we identified a family of 55 pairs of CetA- and CetB-like proteins (which we call HAMP/PAS pairs) in a diverse group of bacterial species (K.T. Elliott, I.B. Zhulin, J.A. Stuckey, V.J. DiRita, in revision). The HAMP domains of this family contain nine conserved residues which we suggest may define a PAS–domain interaction surface. Single alanine substitutions at these positions do not alter the localization of CetB to the membrane. If these conserved residues are involved in CetA–CetB interactions, we predict that substitutions at multiple positions within this region may lead to a change in CetB stability, CetB membrane localization and/or CetA–CetB complex formation. Our in vivo cross-linking experiments also indicate that CetB forms a homodimer (Fig. 7B We can make some predictions about CetB based on sequence comparisons with the PAS domain of Aer. Three residues in the PAS domain of Aer (Arg-57, His-58 and Asp-60) are required for FAD binding (Repik et al., 2000), are located close to the predicted FAD binding site and are conserved in Aer-like (FAD-binding) PAS domains (personal communication in Taylor, 2007). These residues align with identical or similar residues in CetB (Arg-50, His-51 and Glu-53). Based on these similarities, we predict that CetB binds an FAD cofactor. Additionally, the HAMP domain of Aer is required for proper folding and FAD binding by the PAS domain. This requirement, however, can be subverted by non-specific suppressor mutations in the PAS domain (S28G, A65V and A99V) which allow FAD binding in the presence of HAMP domain point mutations that usually abrogate FAD binding (Watts et al., 2004; Buron-Barral et al., 2006). These suppressing residues (Gly-28, Val-65 and Val-99) are the naturally occurring residues at the equivalent positions in CetB (Gly-21, Val-58 and Val-92). This intriguing fact suggests the hypothesis that CetB may fold and bind FAD without interacting with the CetA HAMP domain. These studies have allowed us to further refine our model of energy taxis signal transduction by CetA and CetB (Fig. 8 Experimental procedures Bacterial strains and culture conditions All bacterial strains and plasmids used in this study are listed in Table 1. DRH212, a spontaneous streptomycin-resistant mutant of the clinical isolate C. jejuni 81–176, was the background strain for all mutants studied and is referred to as wild type (Hendrixson et al., 2001). C. jejuni was routinely grown on Mueller–Hinton (MH) agar with 10 μg ml−1 trimethoprim under microaerobic conditions (85% N2, 10% CO2, 5% O2) in a tri-gas incubator. Biphasic cultures were grown in 20 ml MH broth overlaid on 20 ml MH agar under microaerobic conditions. For C. jejuni, the following antibiotic concentrations were used: 10 μg ml−1 trimethoprim, 30 μg ml−1 cefaperazone, 50 μg ml−1 kanamycin, 20 μg ml−1 chloramphenicol and 0.1 or 2 mg ml−1 streptomycin. E. coli was grown in Luria–Bertani (LB) agar or broth. For E. coli, the following antibiotic concentrations were used: 50 μg ml−1 kanamycin, 30 μg ml−1 chloramphenicol or 100 μg ml−1 ampicillin.
Construction of ΔcetAB deletion mutant The ΔcetAB deletion mutant was constructed essentially as described by Hendrixson et al. (2001). The cetA and cetB coding sequences with 1036 bp upstream and 595 bp downstream were amplified by PCR with primers designed with KpnI sites at their 5′ ends for cloning into pUC19. The resulting plasmid was pKTY60. A deletion from the first codon of cetA to the last codon of cetB was created via Pfu mutagenesis (Weiner et al., 1994). This plasmid, pKTY62, was electroporated into DRH304, which harbours the cat-rpsL cassette in the cetB coding sequence. Transformants were selected on 2 mg ml−1 streptomycin and screened for sensitivity on 20 μg ml−1 chloramphenicol. The deletion was confirmed by PCR analysis and chromosomal sequencing. Construction of plasmids for gene expression in C. jejuni To construct a kanamycin selectable plasmid for gene expression in C. jejuni, an 82 bp fragment containing the promoter for the C. jejuni chloramphenicol acetyltransferase (cat) gene from pRY109 (Yao et al., 1993) was amplified by PCR using primers containing 5′ XbaI and BamHI sites. These primers were used to amplify the 82 bp fragment, and the resulting fragment cloned into pRY108 (Yao et al., 1993) giving rise to the plasmid pECO101. Except for antibiotic selection, pECO101 functions similarly to the previously constructed plasmid pECO102 (Wiesner et al., 2003). To construct a plasmid expressing cetB from the cat promoter, the cetB coding sequence was amplified by PCR with primers containing restriction sites so that a BamHI site was added immediately 5′ to cetB and an XhoI site immediately 3′ to cetB for cloning into pECO101. To construct a plasmid expressing both cetA and cetB from the cat promoter, the cetA and cetB coding sequences and intergenic region were amplified by PCR with primers containing restriction sites so that a BclI site was added immediately 5′ to cetA and an XhoI site immediately 3′ to cetB. The resulting fragment was digested with BclI and XhoI and cloned into the BamHI and XhoI sites of pECO101. All plasmids were confirmed by DNA sequencing. Construction of a plasmid to complement the ΔcetAB mutant pKTY60 was digested with ApaLI and BsrBI. The resulting fragment containing the cetA and cetB coding sequences, along with 299 bases upstream and 202 bases downstream, was blunted by T4 DNA polymerase. This fragment was then cloned into the XmnI site in the E. coli/C. jejuni shuttle vector pRY108 (Yao et al., 1993). The resulting plasmid, pKTY360, lacks the 5′ 325 bp of the cj1191c open-reading frame. Site-directed mutagenesis Mutation of the cetA coding sequence leading to an alanine substitution at residue 116 (Y116A) was made in pKTY60 using Pfu mutagenesis (Weiner et al., 1994). DNA sequence of the resulting plasmid was determined to confirm the presence of the point mutation and ensure the absence of additional mutations. This plasmid was then digested with ApaLI and BsrBI and the resulting fragment cloned into the XmnI site of pRY108 as described above. The orientation of the insertions into pRY108 was checked by multiple restriction digests to confirm that the resulting plasmid is identical to pKTY360 except for the indicated point mutations. Conjugation of plasmids into C. jejuni Plasmids were conjugated into C. jejuni as described by Guerry et al. (1994). Briefly, C. jejuni was grown on MH agar with 10 μg ml−1 trimethoprim for 16–20 h and re-suspended in MH broth to an OD600 of 1.0. Overnight cultures of the E. coli donor strain [DH5α(pRK212.1) containing the plasmid to be conjugated into C. jejuni] were diluted into fresh LB broth and grown to an OD600 of 0.5. A total of 500 μl of the donor culture was centrifuged and the pellet washed twice with MH broth, then re-suspended in 1 ml of the C. jejuni recipient culture. This mixture was spotted onto MH agar with no antibiotics. After 5 h at 37°C in microaerobic conditions, the bacteria were re-suspended and spread onto MH agar containing 10 μg ml−1 trimethoprim, 30 μg ml−1 cefaperazone, 2 mg ml−1 streptomycin and 50 μg ml−1 kanamycin. PCR was used to verify transfer of the plasmid to the recipient C. jejuni strain. RNA extractions and RT-PCR Campylobacter jejuni strains were grown in biphasic cultures for 48 h. RNA extractions were performed using Qiagen RNAprotect and Qiagen RNeasy according to manufacturer's instructions, without the use of on-column DNase treatment. To eliminate contaminating DNA, 10× DNase buffer (200 mM sodium acetate pH 4.5, 100 mM MgCl2, 100 mM NaCl) and 10 units of DNase I (RNase-free, Roche) were added to each RNA sample and incubated at room temperature for 1 h. DNase was removed by sequential phenol and chloroform extractions, followed by ethanol precipitation. The final concentration of RNA in each sample was quantified by OD260. Qualitative RT-PCR was performed as follows. A total of 2.5 μg of RNA was mixed with 3 μg random primers (Invitrogen) and cDNA synthesized using MMLV reverse transcriptase (Invitrogen) according to manufacturer's instructions. Control reactions with MMLV reverse transcriptase omitted were performed simultaneously to detect any contaminating DNA. Equal amounts of cDNA products were then used as a template for PCR using either two primers within rpoA or one primer within cetA and one primer within cetB. Control reactions using genomic DNA as a template were also performed. RT-PCR products were separated on a 0.8% agarose gel and visualized with ethidium bromide. SDS-PAGE and Western blots For SDS-PAGE of whole cell lysates, C. jejuni strains were grown on MH agar for 16–20 h, then re-suspended in MH broth to an OD600 of 0.8. The bacteria were pelleted by centrifugation and the pellet re-suspended in 100 μl 2× sample buffer. All other samples were normalized by protein concentration or OD600 as indicated below. Samples were boiled then separated on 10% or 12.5% polyacrylamide gels (as indicated). Proteins were transferred to nitrocellulose membranes and probed with rabbit anti-CetA (1:10 000–1:75 000, generated against an internal peptide by Open Biosystems) or rabbit anti-CetB (1:500–1:5000, generated against an internal peptide by Open Biosystems) followed by either goat anti-rabbit alkaline phosphatase-conjugated secondary antibody (1:10 000, Zymed) or goat anti-rabbit peroxidase-conjugated secondary antibody (1:20 000, Pierce). For detection of CtsP-FLAG, membranes were probed with anti-FLAG peroxidase-conjugated antibody (1:1000, Sigma). Alkaline phosphatase probed Western blots were developed using the chromogenic substrate 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium as previously described (Sambrook et al., 1989). Peroxidase-probed Western blots were developed using the Western Lightning kit (PerkinElmer). Topology predictions Transmembrane domain predictions were preformed using DAS (http://www.sbc.su.se/~miklos/DAS). Signal sequence predictions were performed using LipoP (http://www.cbs.dtu.dk/services/LipoP). Hydrophobicity of individual residues within the predicted CetA transmembrane region was assessed by plotting the Kyte–Doolittle value of each residue in this region. This approach resembles that used recently to analyse the attributes of individual HAMP domain residues (Hulko et al., 2006) and differs from the usual Kyte–Doolittle analysis, which gives the average hydrophobicity of 19 residues centred at each position. Topology analysis using PhoA and LacZ fusions The plasmids pTrcphoA and pTrclacZ were used to construct plasmids containing C-terminal PhoA or LacZ fusions to full-length or truncated CetA. pTrcphoA consists of the coding sequence for phoA without codons 1–26 (the signal sequence), denoted ‘phoA, cloned into pTrc99a’ (Blank and Donnenberg, 2001). pTrclacZ consists of the coding sequence of lacZ without codons 1–7, denoted ‘lacZ, cloned into pTrc99a’ (Blank and Donnenberg, 2001). Truncations of cetA consisting of the first 24, first 50 or first 140 codons and full-length cetA were amplified using primers that added an NcoI site immediately 5′ and an XmaI site immediately 3′ to the coding sequence for cloning into the NcoI and XmaI sites of pTrcphoA and pTrclacZ. The first five codons of cetA were inserted between the NcoI and XmaI sites of pTrcphoA and pTrclacZ using Pfu mutagenesis (Weiner et al., 1994). All resulting plasmids were confirmed by DNA sequencing. Each of the above plamids, including the original vectors, was transformed into E. coli strain TG1, which lacks phoA and lacZ. Alkaline phosphatase and β-galactosidase activities of each strain were assessed as previously described (Miller, 1972; Manoil, 1991). Assays were performed in triplicate and the average and standard deviation calculated for each strain. Subcellular fractionation Campylobacter jejuni strains were grown on MH agar for 16–20 h and re-suspended in 10 mM HEPES pH 7.4. Cells were lysed by one freeze-thaw cycle, followed by sonication 3–6 times for 10 s. Cellular debris was removed by centrifugation at 10 000 g for 10 min. Soluble and membrane fractions were separated by ultracentrifugation at 100 000 g for 1 h. Following ultracentrifugation, the supernatant contained soluble (cytoplasmic and periplasmic proteins) and the pellet contained insoluble (membrane) proteins. Protein concentrations were quantified using the Bio-Rad Protein Assay. Equal amounts of protein from each sample were run on SDS-PAGE for Western analysis. Isocitrate dehydrogenase assays Subcellular fractions were assayed for isocitrate dehydrogenase activity as previously described (Myers and Kelly, 2005). Briefly, equal amounts of protein from each fraction were incubated with 5 mM Tris pH 8.0, 1 mM nicotinamide adenine dinucleotide phosphate (NADP), 1 mM MgCl2 and 5 mM sodium isocitrate at room temperature. Isocitrate dehydrogenase activity was monitored by measuring the rate of increase of OD340, which represents the rate of NADPH production. The per cent of isocitrate dehydrogenase specific activity within each fraction was determined. For all fractionation experiments, at least 90% of the isocitrate dehydrogenase specific activity was found in the soluble fraction. Membrane extraction Campylobacter jejuni strains were grown and fractionated into soluble and membrane fractions as described above. The membrane fraction was then re-suspended in 10 mM HEPES pH 7.4, incubated at 4°C with rocking for 30 min to 1 h, followed by ultracentrifugation at 100 000 g for 1 h. This wash step was repeated three times. The washed membrane fraction was then mixed 1:1 with 10 mM HEPES pH 7.4 or 10 mM HEPES pH 7.4 containing 3 M urea, 5 M urea, 12 M urea, 1 M NaCl or 3 M NaCl (concentrations given are twice the final concentration). These mixtures were incubated at 4°C with rocking for 30 min to 1 h, followed by ultracentrifugation at 100 000 g for 1 h. Following ultracentrifugation, the supernatant contained soluble proteins and the pellet insoluble proteins. The soluble proteins were precipitated with cold acetone. Both soluble and insoluble samples were re-suspended in an equal volume of 10 mM HEPES pH 7.4 and mixed 1:1 with 2× sample buffer. Equal volumes of each sample were used for SDS-PAGE and Western analysis. In vivo cross-linking Campylobacter jejuni strains were grown on MH agar for 16–20 h then re-suspended in MH broth to an OD600 of 8.0. A total of 2.5 mM dithiobis(succinimidyl)propionate (DSP) in DMSO was added to each culture, with additional DMSO added to bring the combined DSP and DMSO volume to 1/10th of the final volume. Untreated samples received 1/10th final volume of DMSO. Samples were incubated at room temperature in ambient atmosphere for 20 min 50 mM Tris pH 8.0 was added to each sample to quench any remaining DSP. Equal volumes of each samples were run on SDS-PAGE without β-mercaptoethanol or DTT added to the sample buffer, as these would cleave the DSP mediated cross-linking. Acknowledgments We thank Erin O'Rourke and Dr David Hendrixson for the construction of pECO101 and Lindsay Davis for assistance with some of the cell fractionation experiments. In addition, we thank Dr Michael Donnenberg for plasmids pTrclacZ and pTrcphoA, as well as E. coli strain TG1. This work was supported by a grant to V.J.D. from the USDA Food Safety Program. K.T.E. was supported by a Howard Hughes Medical Institute Predoctoral Fellowship and a Willison Predoctoral Fellowship. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Mol Microbiol. 1998 May; 28(4):683-90.
[Mol Microbiol. 1998]Annu Rev Microbiol. 1999; 53():103-28.
[Annu Rev Microbiol. 1999]FEMS Microbiol Rev. 2004 Feb; 28(1):113-26.
[FEMS Microbiol Rev. 2004]Proc Natl Acad Sci U S A. 1997 Sep 30; 94(20):10541-6.
[Proc Natl Acad Sci U S A. 1997]Mol Microbiol. 2007 Sep; 65(6):1415-24.
[Mol Microbiol. 2007]FEMS Microbiol Lett. 1999 Jul 1; 176(1):111-6.
[FEMS Microbiol Lett. 1999]J Bacteriol. 2006 Feb; 188(3):894-901.
[J Bacteriol. 2006]Proc Natl Acad Sci U S A. 1996 Mar 19; 93(6):2545-50.
[Proc Natl Acad Sci U S A. 1996]Trends Microbiol. 2007 Oct; 15(10):456-61.
[Trends Microbiol. 2007]Nat Rev Microbiol. 2007 Sep; 5(9):665-79.
[Nat Rev Microbiol. 2007]Mol Microbiol. 2001 Apr; 40(1):214-24.
[Mol Microbiol. 2001]Mol Microbiol. 2003 Oct; 50(2):687-702.
[Mol Microbiol. 2003]Mol Microbiol. 2001 Apr; 40(1):214-24.
[Mol Microbiol. 2001]Protein Eng. 1997 Jun; 10(6):673-6.
[Protein Eng. 1997]J Mol Biol. 1999 Apr 23; 288(1):141-5.
[J Mol Biol. 1999]J Mol Biol. 1999 Nov 5; 293(4):807-14.
[J Mol Biol. 1999]Proc Natl Acad Sci U S A. 1989 Dec; 86(23):9446-50.
[Proc Natl Acad Sci U S A. 1989]J Mol Biol. 1988 Apr 5; 200(3):501-11.
[J Mol Biol. 1988]Microbiol Rev. 1985 Dec; 49(4):398-418.
[Microbiol Rev. 1985]Science. 1986 Sep 26; 233(4771):1403-8.
[Science. 1986]J Bacteriol. 1990 Feb; 172(2):1035-42.
[J Bacteriol. 1990]J Biol Chem. 1988 Sep 15; 263(26):13130-7.
[J Biol Chem. 1988]Mol Microbiol. 1988 Sep; 2(5):655-63.
[Mol Microbiol. 1988]Microbiology. 2005 Jan; 151(Pt 1):233-42.
[Microbiology. 2005]Mol Microbiol. 2003 Mar; 47(5):1459-73.
[Mol Microbiol. 2003]Cell. 1985 Sep; 42(2):497-505.
[Cell. 1985]Cell. 1996 May 3; 85(3):379-89.
[Cell. 1996]Virology. 1996 Jun 1; 220(1):37-45.
[Virology. 1996]Virology. 2001 May 25; 284(1):70-81.
[Virology. 2001]Mol Microbiol. 2001 Apr; 40(1):214-24.
[Mol Microbiol. 2001]Mol Microbiol. 2003 Oct; 50(2):687-702.
[Mol Microbiol. 2003]FEMS Microbiol Lett. 2001 Aug 21; 202(2):243-50.
[FEMS Microbiol Lett. 2001]J Bacteriol. 2006 Mar; 188(6):2233-43.
[J Bacteriol. 2006]J Mol Biol. 1999 Apr 23; 288(1):141-5.
[J Mol Biol. 1999]J Mol Biol. 1999 Nov 5; 293(4):807-14.
[J Mol Biol. 1999]J Bacteriol. 2006 Feb; 188(3):894-901.
[J Bacteriol. 2006]Mol Microbiol. 2001 Apr; 40(1):214-24.
[Mol Microbiol. 2001]Genome Biol. 2007; 8(7):R130.
[Genome Biol. 2007]Mol Microbiol. 2007 Sep; 65(6):1415-24.
[Mol Microbiol. 2007]Mol Microbiol. 2000 May; 36(4):806-16.
[Mol Microbiol. 2000]Mol Microbiol. 2007 Sep; 65(6):1415-24.
[Mol Microbiol. 2007]J Bacteriol. 2004 Nov; 186(21):7440-9.
[J Bacteriol. 2004]J Bacteriol. 2006 May; 188(10):3477-86.
[J Bacteriol. 2006]Mol Microbiol. 2001 Apr; 40(1):214-24.
[Mol Microbiol. 2001]Mol Microbiol. 2001 Apr; 40(1):214-24.
[Mol Microbiol. 2001]Gene. 1994 Dec 30; 151(1-2):119-23.
[Gene. 1994]Gene. 1993 Aug 16; 130(1):127-30.
[Gene. 1993]J Bacteriol. 2003 Sep; 185(18):5408-18.
[J Bacteriol. 2003]Gene. 1993 Aug 16; 130(1):127-30.
[Gene. 1993]Gene. 1994 Dec 30; 151(1-2):119-23.
[Gene. 1994]Methods Enzymol. 1994; 235():474-81.
[Methods Enzymol. 1994]Cell. 2006 Sep 8; 126(5):929-40.
[Cell. 2006]J Bacteriol. 2001 Aug; 183(15):4435-50.
[J Bacteriol. 2001]Gene. 1994 Dec 30; 151(1-2):119-23.
[Gene. 1994]Methods Cell Biol. 1991; 34():61-75.
[Methods Cell Biol. 1991]Microbiology. 2005 Jan; 151(Pt 1):233-42.
[Microbiology. 2005]